Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Medical Oncologists Incredulous at the Commission’s Latest Backtracking on the Evaluation of the EU Tobacco Products Directive

02 May 2024

Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists and its subsequent decision not to bring forward the proposed Council recommendation on smoke-free environments, it is beyond belief that the Commission now appears to have removed plans to publish an evaluation – originally meant to come in 2022 - of the Tobacco Products Directive from its implementation roadmap on the Beating Cancer Plan.

ESMO’s Director of Public Policy, Professor Jean-Yves Blay, stated: “With evidence emerging that new products like e-cigarettes and heated tobacco products pose serious health risks, the Commission’s lack of action in this area is frankly incomprehensible, particularly given the Beating Cancer Plan’s commitment to ‘addressing key risk factors such as tobacco and with the aim to ensure that less than 5% of the population uses tobacco by 2040.’ As we approach the European elections and the appointment of the next College of Commissioners, we call on Europe’s citizenry to vote for candidates who will genuinely prioritize the delivery of the Beating Cancer Plan and not be distracted from this crucial task by the siren calls of the tobacco lobby.”

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.